콘텐츠로 건너뛰기
Merck
  • Fast-track to a solid dispersion formulation using multi-way analysis of complex interactions.

Fast-track to a solid dispersion formulation using multi-way analysis of complex interactions.

Journal of pharmaceutical sciences (2012-12-06)
Jian X Wu, Frans van den Berg, Søren V Søgaard, Jukka Rantanen
초록

Several factors with complex interactions influence the physical stability of solid dispersions, thus highlighting the need for efficient experimental design together with robust and simple multivariate model. Design of Experiments together with ANalysis Of VAriance (ANOVA) model is one of the central tools when establishing a design space according to the Quality by Design (QbD) approach. However, higher order interaction terms are often significant in these ANOVA models, making the final model difficult to interpret and understand. As this is ordinarily the purpose of applying ANOVA, it poses an obvious problem. In the current study, the GEneralized Multiplicative ANOVA (GEMANOVA) model is proposed as an alternative for the ANOVA model. Two complex multivariate data sets obtained by monitoring the physical stability of a solid dispersion with image analysis and X-ray powder diffraction (XRPD) as responses were subjected to GEMANOVA analysis. The results showed that the obtained GEMANOVA model was easier to interpret and understand than the additive ANOVA model. Furthermore, the GEMANOVA model has additional advantages such as the possibility of readily including multivariate responses (e.g., an entire spectral data set), model uniqueness, and curve resolution abilities.

MATERIALS
제품 번호
브랜드
제품 설명

Piroxicam, European Pharmacopoeia (EP) Reference Standard
Piroxicam for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Piroxicam, meets USP testing specifications
Sigma-Aldrich
Piroxicam, ≥98% (TLC)